Arthur F. Ryan - 07 Nov 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Issuer symbol
REGN
Transactions as of
07 Nov 2023
Net transactions value
-$82,790
Form type
4
Filing time
08 Nov 2023, 16:07:20 UTC
Previous filing
03 Aug 2023
Next filing
04 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $4,948 -6 -0.03% $824.59 18,641 07 Nov 2023 Direct F1, F2
transaction REGN Common Stock Sale $14,860 -18 -0.1% $825.53 18,623 07 Nov 2023 Direct F1, F3
transaction REGN Common Stock Sale $3,306 -4 -0.02% $826.58 18,619 07 Nov 2023 Direct F1, F4
transaction REGN Common Stock Sale $9,104 -11 -0.06% $827.65 18,608 07 Nov 2023 Direct F1, F5
transaction REGN Common Stock Sale $32,313 -39 -0.21% $828.54 18,569 07 Nov 2023 Direct F1, F6
transaction REGN Common Stock Sale $14,930 -18 -0.1% $829.43 18,551 07 Nov 2023 Direct F1, F7
transaction REGN Common Stock Sale $2,491 -3 -0.02% $830.39 18,548 07 Nov 2023 Direct F1, F8
transaction REGN Common Stock Sale $838 -1 -0.01% $838.46 18,547 07 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.
F2 Represents volume-weighted average price of sales of 6 shares of Company stock on November 7, 2023 at prices ranging from $824.14 to $824.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
F3 Represents volume-weighted average price of sales of 18 shares of Company stock on November 7, 2023 at prices ranging from $825.04 to $825.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
F4 Represents volume-weighted average price of sales of 4 shares of Company stock on November 7, 2023 at prices ranging from $826.44 to $826.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
F5 Represents volume-weighted average price of sales of 11 shares of Company stock on November 7, 2023 at prices ranging from $827.03 to $827.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
F6 Represents volume-weighted average price of sales of 39 shares of Company stock on November 7, 2023 at prices ranging from $828.01 to $828.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
F7 Represents volume-weighted average price of sales of 18 shares of Company stock on November 7, 2023 at prices ranging from $829.10 to $829.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
F8 Represents volume-weighted average price of sales of 3 shares of Company stock on November 7, 2023 at prices ranging from $830.04 to $830.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.